PubMed ID:
34170930
Public Release Type:
Journal
Publication Year: 2021
Affiliation: Division of Academic Internal Medicine and Geriatrics, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.; Department of Medical Education, Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, United States of America.; Institute for Health and Research Policy, University of Illinois at Chicago, Chicago, Illinois, United States of America.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.; Division of Academic Internal Medicine and Geriatrics, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.
DOI:
https://doi.org/10.1371/journal.pone.0252501
Authors:
Man Bernice, Schwartz Alan, Pugach Oksana, Xia Yinglin, Gerber Ben
Request IDs:
21482
Studies:
Diabetes Prevention Program
Without treatment, prediabetic women with a history of gestational diabetes mellitus (GDM) are at greater risk for developing type 2 diabetes compared with women without a history of GDM. Both intensive lifestyle intervention and metformin can reduce risk. To predict risk and treatment response, we developed a risk prediction model specifically for women with prior GDM.